Descripción de negocio
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Consejo de gestión & Consejo de supervisión
| CEO |
| Kevin Sayer |
| Consejo de gestión |
| Jereme Sylvain, Andrew K. Balo, Barry Regan, Chad Patterson, Don Abbey, Jake Leach, Paul Flynn, Sadie Stern, Shelly Selvaraj, Steven R. Pacelli, Sumi Shrishrimal |
| Consejo de supervisión |
| Kevin Sayer, Barbara E. Kahn, Bridgette Heller, Eric J. Topol, M.D., Jay Skyler, M.D., Karen Dahut, Kyle Malady, Mark Foletta, Nick Augustinos, Richard Collins, Steven R. Altman |
Datos de la empresa
| Nombre: |
Dexcom Inc. |
| Dirección: |
6340 Sequence Drive,San Diego, CA 92121, USA |
| Teléfono: |
+1-858-200-0200 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.dexcom.com/ |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
Biotechnology |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Steve Pacelli |
| IR teléfono: |
- |
| IR-fax: |
- |
| IR e-mail: |
spacelli@dexcom.com
|
